Fidelity Investments’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$707M Sell
10,723,140
-2,084,612
-16% -$132M 0.04% 392
2025
Q4
$814M Sell
12,807,752
-283,895
-2% -$17.7M 0.04% 356
2025
Q3
$720M Buy
13,091,647
+1,824,136
+16% +$75.1M 0.04% 388
2025
Q2
$372M Buy
11,267,511
+951,380
+9% +$33.1M 0.02% 601
2025
Q1
$415M Sell
10,316,131
-478,555
-4% -$22M 0.03% 519
2024
Q4
$508M Sell
10,794,686
-1,299,568
-11% -$67.5M 0.03% 464
2024
Q3
$639M Buy
12,094,254
+571,126
+5% +$31.8M 0.04% 392
2024
Q2
$624M Buy
11,523,128
+621,985
+6% +$37.5M 0.04% 370
2024
Q1
$764M Sell
10,901,143
-2,106,640
-16% -$163M 0.05% 332
2023
Q4
$1.09B Buy
13,007,783
+1,016,959
+8% +$36.8M 0.08% 211
2023
Q3
$353M Sell
11,990,824
-172,144
-1% -$5.73M 0.03% 497
2023
Q2
$397M Sell
12,162,968
-701,844
-5% -$26M 0.03% 483
2023
Q1
$453M Sell
12,864,812
-495,146
-4% -$20.2M 0.04% 444
2022
Q4
$612M Buy
13,359,958
+471,287
+4% +$20.3M 0.06% 320
2022
Q3
$624M Buy
12,888,671
+84,810
+0.7% +$4.08M 0.07% 288
2022
Q2
$503M Buy
12,803,861
+97,495
+0.8% +$3.93M 0.05% 378
2022
Q1
$468M Buy
12,706,366
+165,817
+1% +$5.89M 0.04% 463
2021
Q4
$572M Buy
12,540,549
+55,542
+0.4% +$2.14M 0.04% 416
2021
Q3
$446M Buy
12,485,007
+3,996,325
+47% +$118M 0.04% 468
2021
Q2
$168M Buy
8,488,682
+4,646,979
+121% +$109M 0.01% 889
2021
Q1
$89.4M Buy
3,841,703
+2,804,132
+270% +$59.9M 0.01% 1116
2020
Q4
$21.6M Sell
1,037,571
-2,318,050
-69% -$42.4M ﹤0.01% 1685
2020
Q3
$72.6M Sell
3,355,621
-153,226
-4% -$3.58M 0.01% 1058
2020
Q2
$82.7M Buy
3,508,847
+576,349
+20% +$10.8M 0.01% 950
2020
Q1
$34.6M Buy
2,932,498
+1,149,373
+64% +$14.7M ﹤0.01% 1174
2019
Q4
$18.9M Buy
1,783,125
+100,208
+6% +$1.03M ﹤0.01% 1616
2019
Q3
$19.2M Buy
1,682,917
+14,222
+0.9% +$179K ﹤0.01% 1592
2019
Q2
$18.8M Sell
1,668,695
-258,129
-13% -$2.49M ﹤0.01% 1644
2019
Q1
$15.6M Buy
1,926,824
+73,141
+4% +$538K ﹤0.01% 1698
2018
Q4
$11.7M Sell
1,853,683
-102,700
-5% -$753K ﹤0.01% 1752
2018
Q3
$19.3M Buy
1,956,383
+70,631
+4% +$567K ﹤0.01% 1694
2018
Q2
$15.7M Sell
1,885,752
-406,700
-18% -$3.38M ﹤0.01% 1804
2018
Q1
$16.5M Sell
2,292,452
-25,100
-1% -$215K ﹤0.01% 1799
2017
Q4
$18.9M Sell
2,317,552
-2,172,394
-48% -$24.7M ﹤0.01% 1743
2017
Q3
$65.1M Sell
4,489,946
-136,800
-3% -$1.87M 0.01% 1177
2017
Q2
$56M Sell
4,626,746
-1,029,170
-18% -$14.3M 0.01% 1249
2017
Q1
$72.7M Buy
5,655,916
+456,502
+9% +$5.34M 0.01% 1119
2016
Q4
$63.2M Buy
5,199,414
+136,758
+3% +$1.45M 0.01% 1191
2016
Q3
$46.5M Buy
5,062,656
+1,754,834
+53% +$18.3M 0.01% 1327
2016
Q2
$31.4M Buy
3,307,822
+1,188,025
+56% +$9.75M ﹤0.01% 1472
2016
Q1
$14.9M Sell
2,119,797
-28,400
-1% -$207K ﹤0.01% 1800
2015
Q4
$22.5M Buy
2,148,197
+245,715
+13% +$2.41M ﹤0.01% 1633
2015
Q3
$12.7M Sell
1,902,482
-1,051,777
-36% -$7.18M ﹤0.01% 1846
2015
Q2
$19.9M Buy
2,954,259
+76,221
+3% +$500K ﹤0.01% 1737
2015
Q1
$19.5M Buy
2,878,038
+144,852
+5% +$1.08M ﹤0.01% 1734
2014
Q4
$21.9M Sell
2,733,186
-473,215
-15% -$2.03M ﹤0.01% 1689
2014
Q3
$11.3M Buy
3,206,401
+123,045
+4% +$517K ﹤0.01% 1961
2014
Q2
$14.7M Buy
3,083,356
+1,007,480
+49% +$6.15M ﹤0.01% 1931
2014
Q1
$19.7M Buy
2,075,876
+203,960
+11% +$1.84M ﹤0.01% 1761
2013
Q4
$12.2M Buy
1,871,916
+20,781
+1% +$137K ﹤0.01% 1904
2013
Q3
$14.1M Buy
+1,851,135
New +$19.9M ﹤0.01% 1824

Other funds holding CYTK